A multicenter dose-escalation trial with denileukin diftitox (ONTAK, DAB389IL-2) in patients with severe psoriasis - Concepedia

Concepedia

Publication | Closed Access

A multicenter dose-escalation trial with denileukin diftitox (ONTAK, DAB389IL-2) in patients with severe psoriasis

67

Citations

14

References

2001

Year

Ann Martin, Elsa Gutierrez, Jennie J. Muglia, Charles J. McDonald, Cynthia Guzzo, Alice B. Gottlieb, Amy Pappert, W. Thomas Garland, Jerry Bagel, Patricia Bacha

Journal of the American Academy of Dermatology

Autoimmune DiseaseSystemic TreatmentSevere PsoriasisImmunologyClinical TrialsDenileukin DiftitoxClinical DermatologyMulticenter Dose-escalation TrialPharmacotherapyDermatologyImmunotherapyMedicine

References

	Year	Citations

Page 1

Page 1